BLANEY JEFFREY,GIBBONS PAUL A,HANAN EMILY,RAWSON THOMAS E,ZHOU AIHE,ZHU BING YAN,MAGNUSON STEVEN R,PASTOR RICHARD,LYSSIKATOS JOSEPH P
申请号：
IN2390/DELNP/2011
公开号：
IN2011DN02390A
申请日:
2011.03.31
申请国别(地区):
IN
年份:
2012
代理人:
摘要：
The invention provides JAK kinase inhibitors of Formula la, enantiomers, diasteriomers or pharmaceutically acceptable salts thereof, wherein R1, R2, R7 and Z are defined herein, a pharmaceutical composition that includes a compound of Formula la and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of treating or lessening the severity of a disease or condition responsive to the inhibition of a JAK kinase activity in a patient.
